The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Thank you to our 2024 Advisory Committee
Lindsay Androski
President and CEO, Roivant Social Ventures
President and CEO, Roivant Social Ventures
Gad Berdugo
Founder and Managing Partner, Explorium Capital LLC
Founder and Managing Partner, Explorium Capital LLC
Michelle Doig
Partner, Head of Corporate Development, Omega Funds
Partner, Head of Corporate Development, Omega Funds
Chris Garabedian
Chairman & CEO, Xontogeny
Chairman & CEO, Xontogeny
Kate Haviland
CEO, Blueprint Medicines
CEO, Blueprint Medicines
Jennifer Hawks Bland
CEO, NewYorkBIO
CEO, NewYorkBIO
Darren Ji, MD, PhD, MBA
Co-Founder, Chairman, Chief Executive Officer, Elpiscience
Anna Kazanchyan, MD
Founder and CEO, Saghmos Therapeutics
Founder and CEO, Saghmos Therapeutics
Evan Loh, MD
CEO, Paratek
CEO, Paratek
Glennis Mehra, PhD
Director, BioLabs New York
Director, BioLabs New York
Kimberly Nearing
Venture Partner, BVCF
Venture Partner, BVCF
Stephen M. Ritoch
Chairman and CEO, Blaise Group International, Inc.
Chairman and CEO, Blaise Group International, Inc.
Philip Ross
Global Chairman, Healthcare Investment Banking, J.P. Morgan
Global Chairman, Healthcare Investment Banking, J.P. Morgan
Jennifer Sheng
Managing Director, Healthcare Equity Capital Markets, Citigroup Global Markets
Managing Director, Healthcare Equity Capital Markets, Citigroup Global Markets
Michael Ward
Vice President, Public Policy, Alliance for Aging Research
Vice President, Public Policy, Alliance for Aging Research
Alethia Young
CFO, Bicycle Therapeutics
CFO, Bicycle Therapeutics
